PDCD1 and neoplasm: Furthermore, there is evidence that enhanced inhibitory-receptor signals in T cells, such as CTLA-4 and PD-1, restrain glucose consumption and glycolytic capacity, leading to dampened mTOR activity and IFN-γ production, thereby allowing tumor progression [208, 209].